Review

Immunological intervention in human diseases

Hideki Ueno¹ , Catherine M Hawrylowicz² and Jacques Banchereau¹

¹  Baylor Institute for Immunology Research and Baylor Research Institute, 3434 Live Oak St, Dallas, TX, 75204, USA

²  Allergy and Respiratory Medicine, King's College London, 5^th Floor Thomas Guy House, Guys Hospital, London, SE1 9RT, UK

author email corresponding author email

Journal of Translational Medicine 2007, 5:59doi:10.1186/1479-5876-5-59

Published:	23 November 2007

Abstract

A recent Keystone Symposium Meeting on "Immunological Intervention in Human Disease" was held in Big Sky, Montana on January, 6–11, 2007, organized by Jacques Banchereau, Federica Sallusto and Robert Coffman. It brought together basic scientists and clinicians from both academia and the pharmaceutical industry to discuss how the immune system is involved in the development of human diseases, including cancer, allergy, autoimmunity, and infectious diseases. We highlight advances in our understanding of the pathogenesis of immune-mediated diseases and future approaches in the immune therapeutic interventions. Considerable progress in the development of model systems and methodologies to monitor human immune responses will help to develop and to evaluate new immune-based therapies at pre-clinical and clinical studies.